Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Aug 2006):

Spirulina attenuates cyclosporine-induced nephrotoxicity in rats.

Full Abstract

Cyclosporine (CsA) causes a dose-related decrease in renal function in experimental animals and humans. The generation of reactive oxygen species (ROS) has been implicated in CsA-induced nephrotoxicity. It was previously shown that Spirulina, a blue-green algae, with antioxidant properties effectively attenuated the doxorubicin-induced cardiotoxicity in mice and cisplatin-induced nephrotoxicity in rat. The present study investigated the nephroprotective role of Spirulina against CsA-induced nephrotoxicity in rats. Spirulina (500 mg kg(-1) b.w.) was administered orally for 3 days before and 14 days concurrently with CsA (50 mg kg-1 b.w.). Rats treated with CsA showed nephrotoxicity as evidenced from a significant elevation in plasma urea, creatinine, urinary N-acetyl-beta-D-glucosaminidase (beta-NAG) and a decrease in creatinine and lithium clearance. Pretreatment with Spirulina protected the rats from CsA-induced nephrotoxicity. The CsA-induced rise in plasma urea and creatinine and the decrease in creatinine and lithium clearance were attenuated by Spirulina. There was a significant increase in plasma and kidney tissue MDA with CsA. Spirulina prevented the rise in plasma and kidney tissue MDA. Histopathology of the kidney from CsA-treated rats showed severe isometric vacuolization and widening of the interstitium. However, pretreatment with Spirulina prevented such changes, and the kidney morphology was comparable to that of the control. Spirulina treatment did not alter the blood CsA levels. These results suggest that Spirulina has a protective effect against nephrotoxicity induced by CsA. This study further supports the crucial role of the antioxidant nature of Spirulina in protecting against CsA-induced oxidative stress.Copyright 2006 John Wiley & Sons, Ltd.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Khan, Mahmood (M); Shobha, Jagdish Chandra (JC); Mohan, Iyyapu Krishna (IK); Rao Naidu, Madireddy Umamaheswara (MU); Prayag, Aruna (A); Kutala, Vijay Kumar (VK);

Affiliation: Department of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad 500 082, India.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Journal of applied toxicology : JAT (J Appl Toxicol), published in England. (Language: eng)

Reference: -2006 Sep-Oct; vol 26 (issue 5) : pp 444-51

Dates: Created 2006/08/24; Completed 2007/08/06; Revised 2007/11/15;

PMID: 16858688, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antioxidants (0) ; Cyclosporine (59865-13-3) ; Creatinine (60-27-5) ; Catalase (EC 1.11.1.6) ; Superoxide Dismutase (EC 1.15.1.1) ; Acetylglucosaminidase (EC 3.2.1.52)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1983
3/30/2006
Higher Relevance Score (25)
Lower Relevance Score (8)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index